Genetic differences play a crucial role in cancer treatment. For instance, patients with BRCA1 or BRCA2 mutations may benefit from PARP inhibitors, while those with HER2-positive breast cancer might respond better to targeted therapies like trastuzumab. Understanding a patient's genetic makeup through genomic testing can help personalize treatment plans to improve efficacy and reduce side effects.
